Dopamine transporter down-regulation following repeated cocaine: Implications for 3,4-methylenedioxymethamphetamine-induced acute effects and long-term neurotoxicity in mice

British Journal of Pharmacology

Volumn 159, Issue 1, 2010, Pages 201-211

  Peraile, I ^a   Torres, E ^a   Mayado, A ^a   Izco, M ^a   Lopez Jimenez, A ^a   Lopez Moreno, J A ^a   Colado, M I ^a   O'Shea, E ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

3,4 methylenedioxymethamphetamine (MDMA, 'ecstasy'); Cocaine; Dopamine transporter; Neurotoxicity; Protein kinase C; Sensitization; Trafficking

Indexed keywords

2,6 DIAMINO N [[1 (1 OXOTRIDECYL) 2 PIPERIDYL]METHYL]HEXANAMIDE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; COCAINE; DOPAMINE TRANSPORTER; PROTEIN KINASE C; SODIUM CHLORIDE;

ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; ENDOSOME; HYPERTHERMIA; LOCOMOTION; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL MEMBRANE; COCAINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOWN-REGULATION; MALE; MICE; MOTOR ACTIVITY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROTOXICITY SYNDROMES; PIPERIDINES; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; REWARD; TIME FACTORS;

EID: 74549169832     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00522.x     Document Type: Article

References (75)

1. Amara SG, Kuhar MJ (1993). Neurotransmitter transporters: Recent progress. Annu Rev Neurosci 16 : 73 93.
2. Bennett BA, Hyde CE, Pecora JR, Clodfelter JE (1993). Long-term cocaine administration is not neurotoxic to cultured fetal mesencephalic dopamine neurons. Neurosci Lett 153 : 210 214.
3. Benuck M, Lajtha A, Reith ME (1987). Pharmacokinetics of systemically administered cocaine and locomotor stimulation in mice. J Pharmacol Exp Ther 243 : 144 149.
4. Blakely RD, Bauman AL (2000). Biogenic amine transporters: regulation in flux. Curr Opin Neurobiol 10 : 328 336.
5. Camarero J, Sanchez V, O'Shea E, Green AR, Colado MI (2002). Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine ('ecstasy')-induced dopamine release and free radical formation in the mouse striatum. J Neurochem 81 : 961 972.
6. Carlsson A, Davis JN, Kehr W, Lindqvist M, Atack CV (1972). Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn Schmiedebergs Arch Pharmacol 275 : 153 168.
7. Cervinski MA, Foster JD, Vaughan RA (2005). Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms. J Biol Chem 280 : 40442 40449.
8. Chang MY, Lee SH, Kim JH, Lee KH, Kim YS, Son H et al. (2001). Protein kinase C-mediated functional regulation of dopamine transporter is not achieved by direct phosphorylation of the dopamine transporter protein. J Neurochem 77 : 754 761.
9. Chefer VI, Shippenberg TS (2002). Changes in basal and cocaine-evoked extracellular dopamine uptake and release in the rat nucleus accumbens during early abstinence from cocaine: quantitative determination under transient conditions. Neuroscience 112 : 907 919.
10. Colado MI, Camarero J, Mechan AO, Sanchez V, Esteban B, Elliott JM et al. (2001). A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain. Br J Pharmacol 134 : 1711 1723.
11. Colado MI, OShea E, Green AR (2004). Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Psychopharmacology (Berl) 173 : 249 263.
12. Daniela E, Brennan K, Gittings D, Hely L, Schenk S (2004). Effect of SCH 23390 on (±)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats. Pharmacol Biochem Behav 77 : 745 750.
13. Daniels GM, Amara SG (1999). Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J Biol Chem 274 : 35794 35801.
14. Di Chiara G, Imperato A (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85 : 5274 5278.
15. Escobedo I, O'Shea E, Orio L, Sanchez V, Segura M, de la Torre R et al. (2005). A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice. Br J Pharmacol 144 : 231 241.
16. Everitt BJ, Robbins TW (2005). Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8 : 1481 1489.
17. Farfel GM, Kleven MS, Woolverton WL, Seiden LS, Perry BD (1992). Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in Rhesus monkey. Brain Res 578 : 235 243.
18. Franklin KBJ, Paxinos G (1997). The Mouse Brain in Stereotaxic Coordinates. Academic Press : San Diego, CA.
19. Giros B, Caron MG (1993). Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 14 : 43 49.
20. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379 : 606 612.
21. Goodman JH, Sloviter RS (1993). Cocaine neurotoxicity and altered neuropeptide Y immunoreactivity in the rat hippocampus; a silver degeneration and immunocytochemical study. Brain Res 616 : 263 272.
22. Granado N, Escobedo I, O'Shea E, Colado I, Moratalla R (2008a). Early loss of dopaminergic terminals in striosomes after MDMA administration to mice. Synapse 62 : 80 84.
23. Granado N, O'Shea E, Bove J, Vila M, Colado MI, Moratalla R (2008b). Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice. J Neurochem 107 : 1102 1112.
24. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI (2003). The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). Pharmacol Rev 55 : 463 508.
25. Gulley JM, Zahniser NR (2003). Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands. Eur J Pharmacol 479 : 139 152.
26. Hitri A, Little KY, Ellinwood EH Jr. (1996). Effect of cocaine on dopamine transporter receptors depends on routes of chronic cocaine administration. Neuropsychopharmacology 14 : 205 210.
27. Itzhak Y, Martin JL (1999). Effects of cocaine, nicotine, dizocipline and alcohol on mice locomotor activity: cocaine-alcohol cross-sensitization involves upregulation of striatal dopamine transporter binding sites. Brain Res 818 : 204 211.
28. Izco M, Marchant I, Escobedo I, Peraile I, Delgado M, Higuera-Matas A et al. (2007). Mice with decreased cerebral dopamine function following a neurotoxic dose of MDMA (3,4-methylenedioxymethamphetamine, 'ecstasy') exhibit increased ethanol consumption and preference. J Pharmacol Exp Ther 322 : 1003 1012.
29. Izenwasser S, Cox BM (1990). Daily cocaine treatment produces a persistent reduction of [3H]dopamine uptake in vitro in rat nucleus accumbens but not in striatum. Brain Res 531 : 338 341.
30. Jayanthi LD, Ramamoorthy S (2005). Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants. AAPS J 7 : E728 E738.
31. Johanson CE, Fischman MW (1989). The pharmacology of cocaine related to its abuse. Pharmacol Rev 41 : 3 52.
32. Johnson MA, Rajan V, Miller CE, Wightman RM (2006). Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease. J Neurochem 97 : 737 746.
33. Koff JM, Shuster L, Miller LG (1994). Chronic cocaine administration is associated with behavioral sensitization and time-dependent changes in striatal dopamine transporter binding. J Pharmacol Exp Ther 268 : 277 282.
34. Koob GF, Bloom FE (1988). Cellular and molecular mechanisms of drug dependence. Science 242 : 715 723.
35. Kuhar MJ, Pilotte NS (1996). Neurochemical changes in cocaine withdrawal. Trends Pharmacol Sci 17 : 260 264.
36. Kula NS, Baldessarini RJ (1991). Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine. Neuropharmacology 30 : 89 92.
37. Letchworth SR, Daunais JB, Hedgecock AA, Porrino LJ (1997). Effects of chronic cocaine administration on dopamine transporter mRNA and protein in the rat. Brain Res 750 : 214 222.
38. Little KY, Elmer LW, Zhong H, Scheys JO, Zhang L (2002). Cocaine induction of dopamine transporter trafficking to the plasma membrane. Mol Pharmacol 61 : 436 445.
39. Loder MK, Melikian HE (2003). The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines. J Biol Chem 278 : 22168 22174.
40. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193 : 265 275.
41. Mathis C, Lehmann J, Ungerer A (1992). The selective protein kinase C inhibitor, NPC 15437, induces specific deficits in memory retention in mice. Eur J Pharmacol 220 : 107 110.
42. Melikian HE, Buckley KM (1999). Membrane trafficking regulates the activity of the human dopamine transporter. J Neurosci 19 : 7699 7710.
43. Norregaard L, Gether U (2001). The monoamine neurotransmitter transporters: structure, conformational changes and molecular gating. Curr Opin Drug Discov Devel 4 : 591 601.
44. O'Shea E, Esteban B, Camarero J, Green AR, Colado MI (2001). Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain. Neuropharmacology 40 : 65 74.
45. Parsons LH, Smith AD, Justice JB Jr. (1991). Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine. Synapse 9 : 60 65.
46. Pilotte NS, Sharpe LG, Kuhar MJ (1994). Withdrawal of repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats. J Pharmacol Exp Ther 269 : 963 969.
47. Ramos M, Goni-Allo B, Aguirre N (2005). Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade. Neuropsychopharmacology 30 : 2180 2191.
48. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987). Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237 : 1219 1223.
49. Robertson MW, Leslie CA, Bennett JP Jr. (1991). Apparent synaptic dopamine deficiency induced by withdrawal from chronic cocaine treatment. Brain Res 538 : 337 339.
50. Robinson TE, Berridge KC (2003). Addiction. Annu Rev Psychol 54 : 25 53.
51. Robinson TE, Berridge KC (2008). Review. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci 363 : 3137 3146.
52. Rossetti ZL, Hmaidan Y, Gessa GL (1992). Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol 221 : 227 234.
53. Samuvel DJ, Jayanthi LD, Manohar S, Kaliyaperumal K, See RE, Ramamoorthy S (2008). Dysregulation of dopamine transporter trafficking and function after abstinence from cocaine self-administration in rats: evidence for differential regulation in caudate putamen and nucleus accumbens. J Pharmacol Exp Ther 325 : 293 301.
54. Sanchez V, Camarero J, Esteban B, Peter MJ, Green AR, Colado MI (2001). The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain. Br J Pharmacol 134 : 46 57.
55. Saraiva L, Fresco P, Pinto E, Gonçalves J (2003). Isoform-selectivity of PKC inhibitors acting at the regulatory and catalytic domain of mammalian PKC-alpha, -betaI, -delta, -eta and -zeta. J Enzyme Inhib Med Chem 18 : 475 483.
56. Schenk S, Gittings D, Johnstone M, Daniela E (2003). Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats. Psychopharmacology (Berl) 169 : 21 27.
57. Schlussman SD, Ho A, Zhou Y, Curtis AE, Kreek MJ (1998). Effects of 'binge' pattern cocaine on stereotypy and locomotor activity in C57BL/6J and 129/J mice. Pharmacol Biochem Behav 60 : 593 599.
58. See RE, Elliott JC, Feltenstein MW (2007). The role of dorsal vs ventral striatal pathways in cocaine-seeking behavior after prolonged abstinence in rats. Psychopharmacology (Berl) 194 : 321 331.
59. Segal DS, Kuczenski R, O'Neil ML, Melega WP, Cho AK (2003). Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge. Neuropsychopharmacology 28 : 1730 1740.
60. Sharpe LG, Pilotte NS, Mitchell WM, De Souza EB (1991). Withdrawal of repeated cocaine decreases autoradiographic. Eur J Pharmacol 203 : 141 144.
61. Shen HW, Hagino Y, Kobayashi H, Shinohara-Tanaka K, Ikeda K, Yamamoto H et al. (2004). Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology 29 : 1790 1799.
62. Staley JK, Hearn WL, Ruttenber AJ, Wetli CV, Mash DC (1994). High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. J Pharmacol Exp Ther 271 : 1678 1685.
63. Sullivan JP, Connor JR, Shearer BG, Burch RM (1991a). 2,6-Diamino-N-([1-oxotridecyl)-2-piperidinyl]methyl)hexanamide (NPC 15437): a selective inhibitor of protein kinase C. Agents Actions 34 : 142 144.
64. Sullivan JP, Connor JR, Tiffany C, Shearer BG, Burch RM (1991b). NPC 15437 interacts with the C1 domain of protein kinase C. An analysis using mutant PKC constructs. FEBS Lett 285 : 120 123.
65. Tilley MR, Gu HH (2008). Dopamine transporter inhibition is required for cocaine-induced stereotypy. Neuroreport 19 : 1137 1140.
66. Trigo JM, Orejarena MJ, Maldonado R, Robledo P (2009). MDMA reinstates cocaine-seeking behaviour in mice. Eur Neuropsychopharmacol 19 : 391 397.
67. Volkow ND, Fowler JS, Wang GJ (2002a). Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behav Pharmacol 13 : 355 366.
68. Volkow ND, Fowler JS, Wang GJ (2003). Positron emission tomography and single-photon emission computed tomography in substance abuse research. Semin Nucl Med 33 : 114 128.
69. Volkow ND, Fowler JS, Wang GJ, Swanson JM (2004). Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry 9 : 557 569.
70. Volkow ND, Wang GJ, Fowler JS, Logan J, Jayne N, Franceschi D et al. (2002b). 'Nonhedonic' food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect. Synapse 44 : 175 180.
71. Wang X, Baumann MH, Xu H, Morales M, Rothman RB (2005 ±)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane. J Pharmacol Exp Ther 314 : 1002 1012.
72. Weiss F, Markou A, Lorang MT, Koob GF (1992). Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res 593 : 314 318.
73. Wilson JM, Nobrega JN, Carroll ME, Niznik HB, Shannak K, Lac ST et al. (1994). Heterogeneous subregional binding patterns of 3H-WIN 35 428 and 3H-GBR 12 935 are differentially regulated by chronic cocaine self-administration. J Neurosci 14 : 2966 2979.
74. Wish ED, Fitzelle DB, O'Grady KE, Hsu MH, Arria AM (2006). Evidence for significant polydrug use among ecstasy-using college students. J Am Coll Health 55 : 99 104.
75. Zahniser NR, Sorkin A (2004). Rapid regulation of the dopamine transporter: role in stimulant addiction? Neuropharmacology 47 : 80 91.